Alexander Robeson
About Alexander Robeson
Alexander Robeson is an Associate Scientist at Precision BioSciences, Inc., focusing on the manipulation of the immune system to combat cancer. He holds a Bachelor of Arts in Biology from Covenant College and a PhD in Molecular Cancer Biology from Duke University.
Work at Precision BioSciences
Alexander Robeson has been employed at Precision BioSciences, Inc. since 2020, serving as an Associate Scientist. His role focuses on CMC Analytics within the Raleigh-Durham, North Carolina area. In this position, he applies his expertise in cancer biology and immunology to contribute to the development of innovative therapeutic strategies.
Education and Expertise
Alexander Robeson obtained a Bachelor of Arts (B.A.) in Biology from Covenant College, where he studied from 2002 to 2006. He further pursued advanced education at Duke University, earning a Doctor of Philosophy (PhD) in Molecular Cancer Biology from 2009 to 2016. His academic background provides a strong foundation in cellular and molecular biology, particularly in the context of cancer and immunobiology.
Background
Prior to his current role, Alexander Robeson held several positions in academic and research institutions. He worked as a PhD Candidate at Duke University School of Medicine in the Sally Kornbluth Lab from 2009 to 2016. He also served as a Postdoctoral Associate in the same lab for six months in 2017. His experience includes a role as a Lead Editor for the Duke Initiative for Science & Society, focusing on Genetics/Genomics and SciPol.
Research and Interests
Alexander Robeson focuses on understanding the suppression of the body's adaptive immune system by cancer and exploring ways to manipulate this response to target tumors. His research interests include developing novel therapeutic strategies that leverage insights from cellular and molecular underpinnings of cancer and immunobiology.
Previous Experience
Before joining Precision BioSciences, Alexander Robeson worked as a Postdoctoral Fellow at the UNC Lineberger Comprehensive Cancer Center from 2017 to 2020. He also held a position as a Research Assistant II at TGen, where he contributed to research in the Michael T. Barrett Lab from 2007 to 2009. His diverse experiences in various research settings have equipped him with a comprehensive understanding of cancer research.